Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder.

Arnold PD, Macmaster FP, Hanna GL, Richter MA, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR.

Brain Imaging Behav. 2009 Mar 1;3(1):64-76.

2.

Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: a preliminary study.

Wu K, Hanna GL, Easter P, Kennedy JL, Rosenberg DR, Arnold PD.

Psychiatry Res. 2013 Mar 30;211(3):214-20. doi: 10.1016/j.pscychresns.2012.07.003. Epub 2012 Nov 13.

3.

Inverse relationship between thalamic and orbitofrontal volumes in obsessive-compulsive disorder.

Rotge JY, Dilharreguy B, Aouizerate B, Martin-Guehl C, Guehl D, Jaafari N, Langbour N, Bioulac B, Tignol J, Allard M, Burbaud P.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Jun 15;33(4):682-7. doi: 10.1016/j.pnpbp.2009.03.011. Epub 2009 Mar 21.

PMID:
19306905
4.

Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder.

Arnold PD, Macmaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR.

Psychiatry Res. 2009 May 15;172(2):136-9. doi: 10.1016/j.pscychresns.2009.02.005. Epub 2009 Mar 25.

5.

Meta-analysis of brain volume changes in obsessive-compulsive disorder.

Rotge JY, Guehl D, Dilharreguy B, Tignol J, Bioulac B, Allard M, Burbaud P, Aouizerate B.

Biol Psychiatry. 2009 Jan 1;65(1):75-83. doi: 10.1016/j.biopsych.2008.06.019. Epub 2008 Aug 21.

PMID:
18718575
6.

Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.

Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP, Easter P, Rose M, Michalopoulou GA, Rosenberg DR.

Am J Psychiatry. 2008 Oct;165(10):1299-307. doi: 10.1176/appi.ajp.2008.08010033. Epub 2008 Apr 15.

PMID:
18413702
7.

Volumetric MRI study of key brain regions implicated in obsessive-compulsive disorder.

Atmaca M, Yildirim H, Ozdemir H, Tezcan E, Poyraz AK.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):46-52. Epub 2006 Jul 20.

PMID:
16859819
8.

Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder.

Dougherty DD, Chou T, Corse AK, Arulpragasam AR, Widge AS, Cusin C, Evans KC, Greenberg BD, Haber SN, Deckersbach T.

J Neurosurg. 2016 Nov;125(5):1087-1093. Epub 2016 Feb 19.

PMID:
26894459
9.

Serotonin transporter gene polymorphism implicates reduced orbito-frontal cortex in obsessive-compulsive disorder.

Atmaca M, Onalan E, Yildirim H, Yuce H, Koc M, Korkmaz S, Mermi O.

J Anxiety Disord. 2011 Jun;25(5):680-5. doi: 10.1016/j.janxdis.2011.03.002. Epub 2011 Mar 8.

PMID:
21441009
10.

Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study.

Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC, Buhagiar CJ, Rosenberg DR.

Neurosci Lett. 2008 Apr 11;435(1):45-50. doi: 10.1016/j.neulet.2008.02.011. Epub 2008 Feb 12.

11.

Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.

Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL.

Arch Gen Psychiatry. 2006 Jul;63(7):778-85.

PMID:
16818867
12.

Volumetric MRI assessment of brain regions in patients with refractory obsessive-compulsive disorder.

Atmaca M, Yildirim B H, Ozdemir B H, Aydin B A, Tezcan A E, Ozler A S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1051-7. Epub 2006 May 9.

PMID:
16687198
13.

A manual and automated MRI study of anterior cingulate and orbito-frontal cortices, and caudate nucleus in obsessive-compulsive disorder: comparison with healthy controls and patients with schizophrenia.

Riffkin J, Yücel M, Maruff P, Wood SJ, Soulsby B, Olver J, Kyrios M, Velakoulis D, Pantelis C.

Psychiatry Res. 2005 Feb 28;138(2):99-113.

PMID:
15766634
14.

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study.

Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA.

Psychopharmacology (Berl). 2004 Aug;174(4):530-8. Epub 2004 Apr 9.

PMID:
15083261
15.

Decreased thalamic glutamate level in unmedicated adult obsessive-compulsive disorder patients detected by proton magnetic resonance spectroscopy.

Zhu Y, Fan Q, Han X, Zhang H, Chen J, Wang Z, Zhang Z, Tan L, Xiao Z, Tong S, Maletic-Savatic M, Li Y.

J Affect Disord. 2015 Jun 1;178:193-200. doi: 10.1016/j.jad.2015.03.008. Epub 2015 Mar 14.

PMID:
25819113
16.

Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.

Alonso P, Gratacós M, Segalàs C, Escaramís G, Real E, Bayés M, Labad J, López-Solà C, Estivill X, Menchón JM.

J Psychiatry Neurosci. 2012 Jul;37(4):273-81. doi: 10.1503/jpn.110109.

17.

Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, Mac Master FP, Stewart CM, Rosenberg DR.

Arch Gen Psychiatry. 2000 May;57(5):449-56.

PMID:
10807485
18.

Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder.

Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR.

Am J Psychiatry. 2004 Jun;161(6):1049-56.

PMID:
15169693
19.

White matter structural alterations in pediatric obsessive-compulsive disorder: relation to symptom dimensions.

Lázaro L, Ortiz AG, Calvo A, Ortiz AE, Moreno E, Morer A, Calvo R, Bargallo N.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:249-58. doi: 10.1016/j.pnpbp.2014.06.009. Epub 2014 Jun 28.

PMID:
24977330
20.

Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder.

Macmaster F, Vora A, Easter P, Rix C, Rosenberg D.

Psychiatry Res. 2010 Feb 28;181(2):97-100. doi: 10.1016/j.pscychresns.2009.08.005. Epub 2010 Jan 13.

Supplemental Content

Support Center